Fu Dehui, Huang Yongwang, Gao Ming
Department of Thyroid and Neck Tumor, Tianjin Medical University Cancer Institute and Hospital, National Clinical Research Center for Cancer Tianjin, China.
Key Laboratory of Cancer Prevention and Therapy, Tianjin's Clinical Research Center for Cancer Tianjin, China.
Int J Clin Exp Pathol. 2019 Nov 1;12(11):4066-4076. eCollection 2019.
As a new type of non-coding RNA, circular RNAs (circRNAs) have been reported to be important regulators of tumor initiation and progression. By using the high-throughput microarray, a recent study demonstrated that the expression of hsa_circ_0057481 is upregulated in human laryngeal cancer. In the present study, we aimed to elucidate the role of hsa_circ_0057481 in laryngeal cancer. We found that hsa_circ_0057481 was significantly upregulated in laryngeal cancer tissues compared with healthy normal specimens. Silencing of hsa_circ_0057481 by siRNAs suppressed cell growth, cell cycle progression, invasive and migration potential, and promoted cell apoptosis in laryngeal cancer HEP-2 and TU212 cells. Mechanistically, hsa_circ_0057481 directly sponges miR-200c in HEP-2 cells. Knockdown of hsa_circ_0057481 suppressed the expression of ZEB1, a best-known target of miR-200c. Moreover, the oncogenic effects of hsa_circ_0057481 were partly dependent on its inhibition on miR-200c. Taken together, our findings showed that hsa_circ_0057481 might act as a novel therapeutic target in laryngeal cancer.
作为一种新型的非编码RNA,环状RNA(circRNAs)已被报道是肿瘤发生和进展的重要调节因子。通过高通量微阵列分析,最近一项研究表明hsa_circ_0057481在人喉癌中表达上调。在本研究中,我们旨在阐明hsa_circ_0057481在喉癌中的作用。我们发现,与健康正常标本相比,hsa_circ_0057481在喉癌组织中显著上调。用小干扰RNA(siRNAs)沉默hsa_circ_0057481可抑制喉癌HEP-2和TU212细胞的生长、细胞周期进程、侵袭和迁移能力,并促进细胞凋亡。机制上,hsa_circ_0057481在HEP-2细胞中直接吸附miR-200c。敲低hsa_circ_0057481可抑制miR-200c最著名的靶标ZEB1的表达。此外,hsa_circ_0057481的致癌作用部分依赖于其对miR-200c的抑制。综上所述,我们的研究结果表明hsa_circ_0057481可能是喉癌的一个新的治疗靶点。